This has been a bit of a hopeful week as weeks go these days. The U.S. Army seems to be closing in on a vaccine that will work against all variants of coronavirus—not just COVID, but SARS, as well. There are now not one, but two antiviral pills aimed at treating the virus in affected individuals and moderating its effects. And studies indicate the new Omicron variant of the virus, while highly contagious, results in a milder form of the disease than that produced by either the original strain or the Delta variant.
